Patents Assigned to PTC Therpeutics, Inc.
  • HCV inhibitor and therapeutic agent combinations
    Patent number: 8927576
    Abstract: The present invention is directed to a combination product for treating or ameliorating hepatitis C virus (HCV) infection or disorders or symptoms associated therewith in a subject in need thereof comprising, a HCV inhibitor and one or more therapeutic agents selected from either or both a HCV protease inhibitor and one or more different therapeutic agents administered in combination in an effective amount to the subject.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: January 6, 2015
    Assignee: PTC Therpeutics, Inc.
    Inventor: Zhengxian Gu